Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Medicines With The Active Ingredient Infliximab (Atc: L04Ab02 - In The Dosage Form Powder For The Here. Of An Infusion Solution Concentrate Or Powder For A Concentrate On The Here.
Deadline - Aug 31, 2027
GT reference number - 118173118
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 118173118
Document Type - Tender Notices
Description - Description: The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient infliximab (ATC: L04AB02-in the daring form powder for the production of an infusion concentrate or powder for a concentrate for the production of an infusion solution) as part of a so-called "open-house model". Under the specification of uniform contractual conditions and uniform access procedures, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies is offered to the conclusion or accession to a discount contract in accordance with Section 130a (8) SG
Gt Ref Id - 118173118
Deadline - Aug 31, 2027
Similar Tenders :
|
Summary:
|
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database